Study explores when AAA surveillance may no longer benefit older patients

New research suggests that surveillance for small abdominal aortic aneurysms (AAA) may not always provide meaningful benefit in older patients, particularly those with significant comorbidities. The data was presented during Plenary Session 5 by Sowmya Mangipudi, MD, MSc. The study…
The kids are alright

“I know I gotta get away and I know if I don’t, I’ll go out of my mind; better leave her behind with the kids, they’re alright, the kids are alright.” – Pete Townshend, The Who Mankind harnesses the power…
Dementia patients see worse outcomes after AAA repair

A cohort study using national Medicare data found patients with Alzheimer’s disease and related dementias face significantly higher risks across different outcomes after elective abdominal aortic aneurysm (AAA) repair. The data were presented at the 2026 annual meeting of the…
SVS updates patient reading materials to ‘improve accessibility’

The Society for Vascular Surgery (SVS) has revamped the patient flyers on YourVascularHealth.org—the Society’s patient-facing online patient resource—in an effort to lower the reading level of the material and improve accessibility for patients. The site contains five flyers on the most…
MDR certification secured for Impede embolization plug devices

Shape Memory Medical announced that its Impede embolization plug product family has received certification as a Class III device under the European Union (EU) Medical Device Regulation (MDR) 2017 The Impede devices, previously CE-marked under the Medical Device Directive 93/42/EEC…
NIH-funded WARRIORS trial advances toward launch

The National Institutes of Health (NIH) has approved funding for the WARRIORS international randomized trial comparing endovascular aneurysm repair (EVAR) with watchful waiting in women with small abdominal aortic aneurysms (AAAs) measuring 4–5.5 centimeters. In the United States, the trial…
Terumo Aortic announces launch of Fenestrated Treo pivotal IDE study in US

Terumo Aortic today announced enrollment of the first patient in the Fenestrated Treo pivotal investigational device exemption (IDE) study in the U.S. This study is designed to evaluate the endovascular repair of juxtarenal and suprarenal aortic aneurysms using the Fenestrated…
ViTAA Medical announces FDA 510(k) clearance for aortic planning platform

ViTAA Medical today announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for AiORTA Plan, which the company describes as a “fully automated, hyper-precise aortic surgery planning solution”. The tool aims to automate key preoperative measurements and…
Positive data show novel delayed-release diameter reduction technique in construction of PMEGs is viable

A novel physician-modified endograft (PMEG) technique for the treatment of thoracoabdominal and complex abdominal aortic aneurysms (TAAA and AAA) involving delayed-release diameter reduction to aortic size and shape—allowing for sequential target vessel cannulation—is safe and effective, according to a new…
Patient-facing literature from SVS found to exceed recommended reading level

A readability analysis of 15 publicly available patient education materials from the SVS found that all but three exceeded the 8th-grade reading level, the threshold at which the average adult in the U.S. reads. Additionally, all 15 breached the 6th-grade…

